The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
The intermediate filament cytoskeleton of epithelial, biphasic, and fibrous malignant pleural mesotheliomas was studied by immunohistochemistry and gel electrophoresis. The results were compared with data similarly obtained from lung adenocarcinomas. All mesotheliomas immunostained with various monoclonal and polyclonal antibodies against cytokeratins. By double immunofluorescence microscopy, coexpression of cytokeratins and vimentin was found in the fusiform cells of biphasic and fibrous mesotheliomas. As determined by two-dimensional gel electrophoresis, lung adenocarcinomas exclusively expressed Cytokeratins 7, 8, 18, and 19, and the same polypeptides were found in the fibrous mesotheliomas. These four cytokeratins were also found in the epithelial and biphasic mesotheliomas, most of which, however, also expressed, additional cytokeratins, such as the basic Polypeptide 5 and, in some cases, Cytokeratins 4, 6, 14, and 17. The results demonstrate the epithelial nature of all types of malignant mesotheliomas and thus justify their classification as carcinomas. When epithelial morphology is evident, the pattern of cytokeratin expression is usually more complex, as indicated by the synthesis, in addition to the "simple epithelial" pattern (7, 8, 18, and 19), of certain cytokeratin polypeptides which hitherto have been presumed to be typical of stratified epithelia. This cytokeratin complexity and the coexpression of vimentin and cytokeratins in certain forms of mesotheliomas indicate that these tumors are a clearly distinct and complex group of carcinomas. Their special cytoskeletal filament protein expression should prove useful in differentiating mesotheliomas from other carcinomas, particularly from adenocarcinomas growing in the lung.
G A
GA
Blobel
R
R
Moll
W W
WW
Franke
K W
KW
Kayser
V E
VE
Gould
D000230:Adenocarcinoma / Q000648:ultrastructure; D000911:Antibodies, Monoclonal; D003599:Cytoskeleton / Q000648:ultrastructure*; D004586:Electrophoresis; D006801:Humans; D007120:Immunochemistry; D007382:Intermediate Filaments / Q000648:ultrastructure*; D007633:Keratins / Q000276:immunology; D008175:Lung Neoplasms / Q000648:ultrastructure; D008654:Mesothelioma / Q000648:ultrastructure*; D008856:Microscopy, Fluorescence; D010997:Pleural Neoplasms / Q000648:ultrastructure*; D014746:Vimentin / Q000276:immunology
D000911:Antibodies, Monoclonal; D014746:Vimentin; D007633:Keratins